×
App Icon
The Standard e-Paper
Join Thousands of Readers
★★★★ - on Play Store
Download Now

US regulator: No evidence yet linking weight-loss drugs to suicidal thoughts

Vocalize Pre-Player Loader

Audio By Vocalize

This image provided by Novo Nordisk in January 2023 shows packaging for the company's Wegovy drug. [AP Photo]

The U.S. Food and Drug Administration said on Thursday its preliminary review did not find evidence that weight-loss drugs such as Novo Nordisk's NOVOb.CO Wegovy were tied to suicidal thoughts and the agency will continue to study the issue.

Still, the FDA, which has listed suicidal thoughts as a potential safety signal for such drugs, said it could not definitively rule out that a small risk may exist due to the limited data available.

Premium Article

Get Full Access for Ksh299/Week.

Fact-first reporting that puts you at the heart of the newsroom. Subscribe for full access.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902
By Sammy Mose 18 hrs ago
Sports
Kirimi powers to glory at VetLab Club event
Sports
Strathmore Swords bounce back to slice Eldonets in league battle
Sports
K'Ogalo silence Muranga Seal to move one win away from title
By AFP 20 hrs ago
Sports
African stars in Europe: Antoine Semenyo wins it for City